drugset / Trial / NCT01405482

Botulinum Toxin Injections for Thoracic Outlet Syndrome

NCT01405482

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Botulinum toxin type A injected into the anterior and middle scalene muscles will reduce the irritation on the neurovascular structures at the interscalene triangle in subjects with TOS. This will lead to reductions in pain and paresthesias, and improvements in function when compared with injection of placebo.

Timeline

Start
2011-08
Primary completion
2012-12
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 100 iu Other